Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204692331> ?p ?o ?g. }
- W3204692331 abstract "With the advent of various vaccines and antimicrobial agents during the 20th century, the control and containment of infectious diseases appeared to be a matter of time. However, studies unveiled the diverse natures of microbes, their lifestyle, and pathogenetic potentials. Since the ground-breaking discovery of the hepatitis B virus (HBV) by Baruch Blumberg and the subsequent development of a vaccine in the early 1980s, the main task of the scientific community has been to develop a proper management strategy for HBV-induced chronic liver diseases. In the early 1980’s, standard interferon (IFN) induced a reduction of HBV DNA levels, followed by the normalization of serum transaminases (alanine aminotransferase, ALT), in some chronic hepatitis B (CHB) patients. However, in the course of time, the limitations of standard IFN became evident, and the search for an alternative began. In the late 1980’s, nucleoside analogs entered the arena of CHB treatment as oral drugs with potent antiviral capacities. At the beginning of the 21st century, insights were developed into the scope and limitations of standard IFN, pegylated-IFN as well as nucleoside analogs for treating CHB. Considering the non-cytopathic nature of the HBV, the presence of covalently closed circular DNA (cccDNA) in the nucleus of the infected hepatocytes and HBV-induced immune-mediated liver damages, a new field of CHB management was initiated by modulating the hosts’ immune system through immune therapy. This review will discuss the nature and design of innovative immune therapy for CHB." @default.
- W3204692331 created "2021-10-11" @default.
- W3204692331 creator A5010157263 @default.
- W3204692331 creator A5016679916 @default.
- W3204692331 creator A5032861890 @default.
- W3204692331 creator A5035134420 @default.
- W3204692331 creator A5047915959 @default.
- W3204692331 creator A5048284955 @default.
- W3204692331 creator A5054809763 @default.
- W3204692331 creator A5070086089 @default.
- W3204692331 creator A5073235102 @default.
- W3204692331 date "2021-09-29" @default.
- W3204692331 modified "2023-09-24" @default.
- W3204692331 title "Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinical" @default.
- W3204692331 cites W1504083424 @default.
- W3204692331 cites W1516127735 @default.
- W3204692331 cites W1551599073 @default.
- W3204692331 cites W1562163928 @default.
- W3204692331 cites W1642222223 @default.
- W3204692331 cites W1855845791 @default.
- W3204692331 cites W1910034918 @default.
- W3204692331 cites W1920295372 @default.
- W3204692331 cites W19219484 @default.
- W3204692331 cites W1924353063 @default.
- W3204692331 cites W1965998220 @default.
- W3204692331 cites W1968540453 @default.
- W3204692331 cites W1970107848 @default.
- W3204692331 cites W1971084304 @default.
- W3204692331 cites W1973171188 @default.
- W3204692331 cites W1977236527 @default.
- W3204692331 cites W1979722884 @default.
- W3204692331 cites W1982756319 @default.
- W3204692331 cites W1983102565 @default.
- W3204692331 cites W1984848689 @default.
- W3204692331 cites W1986329557 @default.
- W3204692331 cites W1987934188 @default.
- W3204692331 cites W1988615815 @default.
- W3204692331 cites W1988855972 @default.
- W3204692331 cites W1990653568 @default.
- W3204692331 cites W1994901499 @default.
- W3204692331 cites W1998931298 @default.
- W3204692331 cites W1999400498 @default.
- W3204692331 cites W2001708692 @default.
- W3204692331 cites W2001856916 @default.
- W3204692331 cites W2002781532 @default.
- W3204692331 cites W2003974063 @default.
- W3204692331 cites W2004375393 @default.
- W3204692331 cites W2006814219 @default.
- W3204692331 cites W2007706733 @default.
- W3204692331 cites W2008401255 @default.
- W3204692331 cites W2008909077 @default.
- W3204692331 cites W2009840176 @default.
- W3204692331 cites W2010843181 @default.
- W3204692331 cites W2011555137 @default.
- W3204692331 cites W2012373025 @default.
- W3204692331 cites W2013874327 @default.
- W3204692331 cites W2015763479 @default.
- W3204692331 cites W2016368479 @default.
- W3204692331 cites W2018196002 @default.
- W3204692331 cites W2018441679 @default.
- W3204692331 cites W2018706343 @default.
- W3204692331 cites W2021647336 @default.
- W3204692331 cites W2033588661 @default.
- W3204692331 cites W2036385674 @default.
- W3204692331 cites W2041879007 @default.
- W3204692331 cites W2043891615 @default.
- W3204692331 cites W2044670404 @default.
- W3204692331 cites W2044751513 @default.
- W3204692331 cites W2045713351 @default.
- W3204692331 cites W2046190679 @default.
- W3204692331 cites W2054350989 @default.
- W3204692331 cites W2055688214 @default.
- W3204692331 cites W2060926084 @default.
- W3204692331 cites W2063407125 @default.
- W3204692331 cites W2064207260 @default.
- W3204692331 cites W2064720744 @default.
- W3204692331 cites W2064823659 @default.
- W3204692331 cites W2068127052 @default.
- W3204692331 cites W2069934268 @default.
- W3204692331 cites W2070670407 @default.
- W3204692331 cites W2071779047 @default.
- W3204692331 cites W2075151840 @default.
- W3204692331 cites W2077583723 @default.
- W3204692331 cites W2084304280 @default.
- W3204692331 cites W2085494369 @default.
- W3204692331 cites W2085833018 @default.
- W3204692331 cites W2086112893 @default.
- W3204692331 cites W2086184370 @default.
- W3204692331 cites W2090679050 @default.
- W3204692331 cites W2102312703 @default.
- W3204692331 cites W2103242107 @default.
- W3204692331 cites W2106052448 @default.
- W3204692331 cites W2108106133 @default.
- W3204692331 cites W2116118057 @default.
- W3204692331 cites W2118780236 @default.
- W3204692331 cites W2119387393 @default.
- W3204692331 cites W2122749974 @default.
- W3204692331 cites W2127121239 @default.
- W3204692331 cites W2129628211 @default.
- W3204692331 cites W2130994191 @default.